What Wall Street is watching

Investors want to know if Eli Lilly is experiencing the same pricing pressures on its blockbuster weight-loss drug Zepbound that…

These drugmakers are catching up to Eli Lilly and Novo Nordisk

The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…